References
- Choi Y, Kim SY, Kim SH, Yang J, Park K, Byun Y. Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft. Int J Cancer 2003;107:145–148.
- Um SJ, Lee SY, Kim EJ, Han HS, Koh YM, Hong KJ et al. Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells. Cancer Lett 2001;174:127–134.
- Hurst RE, Waliszewski P, Waliszewska M, Bonner RB, Benbrook DM, Dar A et al. Complexity, retinoid-responsive gene networks, and bladder carcinogenesis. Adv Exp Med Biol 1999;462:449–467.
- Reynolds CP, Matthay KK, Villablanca JG, Maurer BJ. Retinoid therapy of high-risk neuroblastoma. Cancer Lett 2003;197:185–192.
- Cui C, Zhang Y, Wang L, Liu H, Cui G. Enhanced anticancer activity of glutamate prodrugs of all-trans retinoic acid. J Pharm Pharmacol 2009;61:1353–1358.
- Hollander D. Retinol lymphatic and portal transport: influence of pH, bile, and fatty acids. Am J Physiol 1980;239:G210–G214.
- Adamson PC, Pitot HC, Balis FM, Rubin J, Murphy RF, Poplack DG. Variability in the oral bioavailability of all-trans-retinoic acid. J Natl Cancer Inst 1993;85:993–996.
- Takitani K, Nakao Y, Kosaka Y, Inoue A, Kawakami C, Kuno T et al. Low plasma level of all-trans retinoic acid after feeding tube administration for acute promyelocytic leukemia. Am J Hematol 2004;76:97–98.
- Lin HS, Chean CS, Ng YY, Chan SY, Ho PC. 2-Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid. J Clin Pharm Ther 2000;25:265–269.
- Lin HS, Chan SY, Low KS, Shoon ML, Ho PC. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration. J Pharm Sci 2000;89:260–267.
- Montassier P, Duchene D, Poelman MC. Inclusion complexes of tretinoin with cyclodextrins. Int J Pharm 1997;153:199–209.
- Qi ZHH, Shieh WJ. Aqueous media for effective delivery of tretinoin. J Incl Phenom Macrocycl Chem 2002;44:133–136.
- Drach J, Lopez-Berestein G, McQueen T, Andreeff M, Mehta K. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid. Cancer Res 1993;53:2100–2104.
- Mehta K, Sadeghi T, McQueen T, Lopez-Berestein G. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leuk Res 1994;18:587–596.
- Estey E, Thall PF, Mehta K, Rosenblum M, Brewer T Jr, Simmons V et al. Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid. Blood 1996;87:3650–3654.
- Douer D, Estey E, Santillana S, Bennett JM, Lopez-Bernstein G, Boehm K et al. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid. Blood 2001;97:73–80.
- Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol 2004;56:1527–1535.
- Lim SJ, Kim CK. Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm 2002;243:135–146.
- Hwang SR, Lim SJ, Park JS, Kim CK. Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration. Int J Pharm 2004;276:175–183.
- Zuccari G, Carosio R, Fini A, Montaldo PG, Orienti I. Modified polyvinylalcohol for encapsulation of all-trans-retinoic acid in polymeric micelles. J Control Release 2005;103:369–380.
- Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: past, present and future. Nat Rev Drug Discov 2004;3:1023–1035.
- Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation and delivery. Pharm Res 1997;14:556–567.
- Dahan A, Miller JM, Hoffman A, Amidon GE, Amidon GL. The solubility-permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone. J Pharm Sci 2010;99:2739–2749.
- Montassier P, Duchene D, Poelman MC. In vitro release study of tretinoin from tretinoin/cyclodextrin derivative complexes. J Inclusion Phenom Mol Recognit Chem 1998;31:213–218.
- Anadolu RY, Sen T, Tarimci N, Birol A, Erdem C. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi. J Eur Acad Dermatol Venereol 2004;18:416–421.
- Amdidouche D, Montassier P, Poelman MC, Duchene D. Evaluation by laser Doppler velocimetry of the attenuation of tretinoin induced skin irritation by β-cyclodextrin complexation. Int J Pharm 1994;111:111–116.
- Ascenso A, Guedes R, Bernardino R, Diogo H, Carvalho FA, Santos NC et al. Complexation and full characterization of the tretinoin and dimethyl-βeta-cyclodextrin complex. AAPS PharmSciTech 2011;12:553–563.
- Sun NY, Wei XL, Wu BJ, Chen J, Lu Y, Wu W. Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powder Technol 2008;182:72–80.
- Zhang XW, Sun NY, Wu BJ, Lu Y, Guan TZ, Wu W. Physical characterization of lansoprazole/PVP solid dispersion prepared by fluid-bed coating technique. Powder Technol 2008;182:480–485.
- Zhang X, Wu D, Lai J, Lu Y, Yin Z, Wu W. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique. J Pharm Sci 2009;98:665–675.
- Lu Y, Zhang XW, Lai J, Yin ZN, Wu W. Physical characterization of meloxicam-β-cyclodextrin inclusion complex pellets prepared by a fluid-bed coating method. Particuology 2009;7:1–8.
- Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation. AAPS PharmSciTech 2004;5:e59.
- Corrigan OI, Stanley CT. Mechanism of drug dissolution rate enhancement from beta-cyclodextrin-drug systems. J Pharm Pharmacol 1982;34:621–626.
- Park KM, Kang HC, Cho JK, Chung IJ, Cho SH, Bae YH et al. All-trans-retinoic acid (ATRA)-grafted polymeric gene carriers for nuclear translocation and cell growth control. Biomaterials 2009;30:2642–2652.
- Lewin AH, Whaley MG, Parker SR, Carroll FI, Moreland CG. 12-Carboxyretinoic acids. Synthesis and structure. J Org Chem 1982;47:1799–1807.
- Englert G. A 13C-NMR. Study of cis-trans isomeric vitamins A, carotenoids and related compounds. Helv Chim Acta 1975;58:2367–2390.
- Waterhous DV, Muccio DD. 1H and 13C NMR studies on the self-association of retinoic acid. Magn Reson Chem 1990;28:223–226.
- Loveday SM, Singh H. Recent advances in technologies for vitamin A protection in foods. Trends Food Sci Technol 2008;19:657–668.